Dergiler / Türk Jinekoloji ve Obstetrik Derneği Dergisi / 2012 / Cilt: 9 - Sayı: 4

Ovarian hiperstimülasyon sendromu: Öngörme, önleme ve tedavisine güncel bakış

Ovarıan hyperstımulaton syndrome: An update for predıctıon, preventıon and treatment

Sayfa
177–185
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

BOZDAĞ, G., ÇALIŞ, P. T. (2022). Ovarian hiperstimülasyon sendromu: Öngörme, önleme ve tedavisine güncel bakış. Türk Jinekoloji ve Obstetrik Derneği Dergisi, Cilt: 9 - Sayı: 4, 177–185. https://ajindex.com/articles/631562

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Devroey P, Polyzos NP, Blockeel C. An OHSS-Free Clinic by segmentation of IVF treatment. Hum Reprod 2011; 26: 2593- 7
  2. Ertzeid G, Storeng R. The impact of ovarian stimulation on implantation and fetal development in mice. Hum Reprod 2001; 16: 221- 5
  3. Kodaman PH, Taylor HS. Hormonal regulation of implantation. Obstet Gynecol Clin North Am 2004; 31: 745- 66
  4. Pena JE, Chang PL, Thornton MH, 2nd, Sauer MV. Serum estradiol levels after 4 days of ovarian hyperstimulation in oocyte donors are predictive of embryo quality and clinical outcomes. Gynecol Obstet Invest 2002; 54: 207- 12
  5. Aramwit P, Pruksananonda K, Kasettratat N, Jammeechai K. Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilization. Am J Health Syst Pharm 2008; 65: 1148- 53
  6. Delvigne A. Symposium: Update on prediction and management of OHSS. Epidemiology of OHSS. Reprod Biomed Online 2009; 19: 8- 13
  7. Navot D, Relou A, Birkenfeld A, Rabinowitz R, Brzezinski A, Margalioth EJ. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol 1988; 159: 210- 5
  8. Delvigne A, Dubois M, Battheu B, Bassil S, Meuleman C, De Sutter P et al. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. II. Multiple discriminant analysis for risk prediction. Hum Reprod 1993; 8: 1361- 6
  9. Tummon I, Gavrilova-Jordan L, Allemand MC, Session D. Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review*. Acta Obstet Gynecol Scand 2005; 84: 611- 6
  10. Kwee J, Elting ME, Schats R, McDonnell J, Lambalk CB. Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization. Reprod Biol Endocrinol 2007; 5: 9
  11. Lee TH, Liu CH, Huang CC, Wu YL, Shih YT, Ho HN et al. Serum anti-Mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod 2008; 23: 160- 7
  12. Broer SL, Dolleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a metaanalysis. Hum Reprod Update 2011; 17: 46- 54
  13. Altmae S, Hovatta O, Stavreus-Evers A, Salumets A. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Hum Reprod Update 2011; 17: 813- 28
  14. Hanevik HI, Hilmarsen HT, Skjelbred CF, Tanbo T, Kahn JA. A single nucleotide polymorp